|
|
US 7,541,443 B2 |
|
| Anti-CD4 antibodies |
| Mark Frewin, Oxford (United Kingdom); Herman Waldmann, Oxford (United Kingdom); Scott Gorman, Witney (United Kingdom); Geoff Hale, Marston (United Kingdom); Patricia Rao, Acton, Mass. (US); Tadeusz Kornaga, Cambridge, Mass. (US); Douglas Ringler, Boston, Mass. (US); Stephen Cobbold, Witney (United Kingdom); and Dawn Winsor-Hines, Framingham, Mass. (US) |
| Assigned to Tolerrx, Inc., Cambridge, Mass. (US); Isis Innovation, Ltd., Oxford (United Kingdom); and Cambridge University Technical Services, Ltd., Cambridge (United Kingdom) |
| Filed on Jan. 29, 2003, as Appl. No. 10/353,708. |
| Application 10/353708 is a continuation in part of application No. 10/171452, filed on Jun. 13, 2002, abandoned. |
| Claims priority of provisional application 60/345194, filed on Oct. 19, 2001. |
| Claims priority of provisional application 60/373470, filed on Apr. 18, 2002. |
| Claims priority of provisional application 60/373471, filed on Apr. 18, 2002. |
| Claims priority of application No. 0114517.6 (GB), filed on Jun. 14, 2001; and application No. 0122724.8 (GB), filed on Sep. 20, 2001. |
| Prior Publication US 2003/0219403 A1, Nov. 27, 2003 |
| Int. Cl. C07K 16/28 (2006.01)
|